Sibutramine (諾美婷) Increases Risk for MI and Stroke

歡迎大家來聊天,這裡不討論健保,大家放輕鬆,什麼都可以談,都可以來聊聊,但是政治相關文章不要在這裡談!

版主: 版主006

回覆文章
熊哥
部長級
部長級
文章: 6777
註冊時間: 週六 7月 12, 2008 3:39 pm
來自: 吳敦義呆了八年,卻沒建設的地方
聯繫:

Sibutramine (諾美婷) Increases Risk for MI and Stroke

文章 熊哥 »

The weight-loss drug sibutramine (Meridia) — up for review by FDA advisers on Sept. 15 — poses increased risk for cardiovascular events among adults with cardiovascular disease (CVD), according to a New England Journal of Medicine study.
Industry-supported researchers randomized nearly 10,000 overweight or obese adults with cardiovascular disease and/or diabetes to receive sibutramine or placebo. During 3.4 years' treatment, sibutramine recipients were at greater risk for nonfatal MI (4.1% vs. 3.2%) and stroke (2.6% vs. 1.9%), although not cardiovascular mortality. In subgroup analyses, the increased risks were seen among subjects with CVD and CVD plus diabetes, but not among those with diabetes alone.
The authors conclude that sibutramine "should continue to be excluded from use in patients with preexisting cardiovascular disease." Editorialists, however, take a stronger stance: "Given that sibutramine has minimal efficacy for weight loss, no apparent benefit for clinical outcomes, [and] a worrisome cardiovascular risk profile, ... it is difficult to discern a credible rationale for keeping this medication on the market."

http://www.nejm.org/doi/full/10.1056/NEJMoa1003114

小心, 遇到一個就會被告死喔 !
傳說中的杜老爺是也 ! http://mypaper.pchome.com.tw/bear1002
xkuk
註冊會員
註冊會員
文章: 20150
註冊時間: 週日 11月 10, 2024 2:04 pm

Re: Sibutramine (諾美婷) Increases Risk for MI and Stroke

文章 xkuk »

回覆文章

回到「★ 談天說地,無所不談,就是不談政治」